✦ LIBER ✦

Inflammation and therapeutic vaccination in CNS diseases

✍ Scribed by Weiner, Howard L.; Selkoe, Dennis J.

Book ID: 109890800
Publisher: Nature Publishing Group
Year: 2002
Tongue: English
Weight: 236 KB
Volume: 420
Category: Article
ISSN: 0028-0836
DOI: 10.1038/nature01325

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of inflammation in CNS injury a

The role of inflammation in CNS injury and disease

✍ Sian-Marie Lucas; Nancy J Rothwell; Rosemary M Gibson 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 155 KB

ChemInform Abstract: Brain Inflammation

ChemInform Abstract: Brain Inflammation in Alzheimer Disease and the Therapeutic Implications

✍ Edith G. McGeer; Patrick L. McGeer 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 24 KB

Peptide-based therapeutic vaccines for a

Peptide-based therapeutic vaccines for allergic and autoimmune diseases

✍ Larché, Mark; Wraith, David C 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 256 KB

Opinion: Therapeutic vaccination for chr

Opinion: Therapeutic vaccination for chronic diseases: a new class of drugs in sight

✍ Bachmann, Martin F.; Dyer, Mark R. 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 256 KB

Glycogen Synthase Kinase-3 (GSK3): Infla

Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and Therapeutics

✍ Richard S. Jope; Christopher J. Yuskaitis; Eléonore Beurel 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 379 KB

Therapeutic apheresis in rheumatological

Therapeutic apheresis in rheumatological diseases

✍ Max Hamburger; Gayl Rogers 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 30 KB 👁 2 views

Dr. Hamburger was asked whether he would recommend the use of cytoxin or lymphacytapheresis first in the treatment of rheumatoid arthritis. He stated that he would recommend lymphacytapheresis first, especially in relatively young patients because of the multiple side effects and the risk of long-te